Method for optimizing electrophysiological characteristics of iPS (induced pluripotent stem)-derived myocardial cells based on optogenetics regulation and control
By designing specific photosensitive ion channel genes and building a three-dimensional microfluidic culture system, combining real-time feedback and machine learning algorithms, the electrophysiological characteristics of iPS-derived cardiomyocytes are optimized, the problems of cell heterogeneity and immatureness are solved, and efficient cell maturation and functional consistency are achieved.
Patent Information
- Application Number
- CN202510148195.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-02-11
- Publication Date
- 2025-05-30
AI Technical Summary
The significant heterogeneity and immatureness of the electrophysiological properties of iPS-derived cardiomyocytes, limiting their application in disease modeling, drug screening, and regenerative medicine. Existing optogenetic methods are difficult to simulate the complex electrophysiological properties of cardiomyocytes, and traditional two-dimensional culture systems are difficult to provide a three-dimensional microenvironment similar to that in vivo.
By designing specific photosensitive ion channel genes, a three-dimensional microfluidic culture system is built to achieve real-time feedback regulation, and integrating advanced machine learning algorithms to comprehensively optimize the electrophysiological characteristics of iPS-derived cardiomyocytes.
It significantly improves the maturity and functional consistency of cardiomyocytes, achieves precise regulation of the electrophysiological characteristics of cardiomyocytes, provides a microenvironment similar to the body, enhances the simulation ability of pathological states, and improves the efficiency of drug screening.
Smart Images

Figure BDA0005267196750000161 
Figure BDA0005267196750000171 
Figure BDA0005267196750000172
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of induced pluripotent stem cells, and particularly to a method for optimizing the electrophysiological properties of iPS-derived cardiomyocytes based on optogenetic regulation. Background Art
[0002] In recent years, the development of induced pluripotent stem cell (iPS) technology has brought new hope for the research and treatment of heart diseases. However, iPS-derived cardiomyocytes still exhibit significant heterogeneity and immaturity in electrophysiological properties, which severely limits their applications in disease modeling, drug screening, and regenerative medicine. Traditional cardiomyocyte culture and regulation methods, such as growth factor treatment, electrical stimulation, and mechanical stretching, although improving the functional properties of cells to a certain extent, still make it difficult to precisely regulate the electrophysiological properties of individual cells.
[0003] Recently, the introduction of optogenetic technology has opened up new avenues for the regulation of cardiomyocyte function. This method regulates the electrical activity of cells by expressing light-sensitive proteins in cells and using light stimulation. However, existing optogenetic methods mainly focus on the regulation of single ion channels and are difficult to simulate the complex electrophysiological properties of cardiomyocytes. In addition, commonly used non-specific light-sensitive proteins often introduce additional ion currents, interfering with the intrinsic electrophysiological properties of cells.
[0004] In terms of cell culture, traditional two-dimensional culture systems are difficult to provide a three-dimensional microenvironment similar to that in vivo, resulting in abnormal cell arrangement and functional connection. Although some researchers have tried to use three-dimensional culture technology, existing methods are difficult to achieve precise control and real-time adjustment of the culture environment.
[0005] In addition, existing methods for optimizing the electrophysiological properties of cardiomyocytes usually lack a real-time feedback mechanism and are difficult to adjust parameters in a timely manner according to the dynamic changes of cells. At the same time, traditional data analysis methods are difficult to handle complex multi-variable non-linear relationships, limiting the efficiency and accuracy of the optimization process.
[0006] In view of the above problems, there is an urgent need to develop a new method that can precisely and dynamically regulate the electrophysiological properties of iPS-derived cardiomyocytes. An ideal method should be able to regulate multiple ion channels simultaneously, provide a culture environment similar to that in vivo, have real-time feedback and intelligent optimization capabilities, thereby significantly improving the maturity and functional consistency of cardiomyocytes. Summary of the Invention
[0007] The method for optimizing the electrophysiological properties of iPS-derived cardiomyocytes based on optogenetic regulation proposed by the present invention aims to solve the above technical problems. This method comprehensively optimizes the electrophysiological properties of iPS-derived cardiomyocytes by designing specific light-sensitive ion channel genes, constructing a three-dimensional microfluidic culture system, achieving real-time feedback regulation, and integrating advanced machine learning algorithms.
[0008] The objective of the present invention is to provide a method for optimizing the electrophysiological properties of iPS-derived cardiomyocytes based on optogenetic regulation, including the following steps:
[0009] (1) Design and construct a specific light-sensitive ion channel gene;
[0010] (2) Targetedly insert the specific light-sensitive ion channel gene into the iPS cell genome;
[0011] (3) Induce the iPS cells to differentiate into cardiomyocytes;
[0012] (4) Use a multi-wavelength LED array system to perform light stimulation on the cardiomyocytes;
[0013] (5) Use a microelectrode array system to monitor the electrophysiological properties of the cardiomyocytes in real time;
[0014] (6) Based on the monitoring results of the electrophysiological properties, optimize the light stimulation parameters through a machine learning algorithm;
[0015] (7) Culture the cardiomyocytes in a 3D-printed microfluidic culture device and perform optogenetic regulation.
[0016] Specifically, the specific light-sensitive ion channel genes in step (1) include:
[0017] The light-sensitive sodium channel gene OptoNav1.5, in which the transmembrane domains 4-7 of the light-sensitive protein ChR2 are inserted into the S3-S4 loop of Nav1.5;
[0018] The light-sensitive potassium channel gene OptoKv11.1, in which the transmembrane domains 3-6 of the light-sensitive protein Arch are inserted into the S5-P loop of Kv11.1;
[0019] The light-sensitive calcium channel gene OptoCav1.2, in which the transmembrane domains 2-5 of the light-sensitive protein VChR1 are inserted into the III-IV loop of Cav1.2.
[0020] Specifically, in step (2), the CRISPR / Cas9 system is used for genome targeted insertion, which specifically includes the following steps:
[0021] (a) Design and synthesize a specific gRNA;
[0022] (b) Prepare a homologous recombination template containing the light-sensitive ion channel gene and 1 kb homologous arms on both sides;
[0023] (c) Use electroporation to transfect the Cas9 protein, gRNA and homologous recombination template into iPS cells;
[0024] (d) Resistance screening was performed using puromycin.
[0025] Specifically, the cardiomyocyte differentiation method in step (3) is a small molecule induction method, which includes the following steps:
[0026] (a) Treat the cells with CHIR99021 from day 0 to day 1 at a concentration of 6 - 12 μM;
[0027] (b) Culture the cells with basal medium RPMI / B27 without insulin from day 2 to day 3;
[0028] (c) Treat the cells with IWP - 2 from day 3 to day 5 at a concentration of 5 - 10 μM;
[0029] (d) Culture the cells with RPMI / B27 medium containing insulin from day 5.
[0030] Specifically, the multi - wavelength LED array system in step (4) includes:
[0031] Blue LED, wavelength 470 ± 5 nm, power density 0 - 50 mW / mm 2 ;
[0032] Yellow LED, wavelength 590 ± 5 nm, power density 0 - 30 mW / mm 2 ;
[0033] Green LED, wavelength 530 ± 5 nm, power density 0 - 40 mW / mm 2 。
[0034] Specifically, the microelectrode array system used in step (5) includes 60 electrodes, the electrode spacing is 200 μm, the electrode diameter is 30 μm, the sampling rate is 10 - 50 kHz, and the band - pass filter range is 0.1 Hz - 3 kHz.
[0035] Specifically, the machine learning algorithms in step (6) include random forest regression, support vector machine regression, and deep neural network, where:
[0036] The number of trees in random forest regression is 100 - 1000, the maximum depth is 5 - 50, and the minimum number of samples in leaf nodes is 1 - 10;
[0037] Support vector machine regression uses a radial basis function kernel, the C parameter range is 0.1 - 100, and the gamma parameter range is 0.001 - 1;
[0038] The number of layers in the deep neural network is 3 - 10, the number of neurons in each layer is 32 - 512, the activation function is ReLU, the optimizer is Adam, and the learning rate is 0.0001 - 0.01.
[0039] Specifically, the preparation method of the three-dimensional printed microfluidic culture device in step (7) includes the following steps:
[0040] (a) Prepare a microfluidic chip using PDMS, where the ratio of the PDMS matrix to the curing agent is 10:1 (w / w);
[0041] (b) Use 3D printing technology to make a mold, with a printing resolution of 25 - 100 μm and a printing speed of 1 - 5 cm / h;
[0042] (c) Pour the PDMS prepolymer into the mold and cure it at 65 °C for 4 - 6 hours;
[0043] (d) Treat the surfaces of the PDMS and the glass slide with plasma, with a power of 50 - 100 W and a time of 30 - 60 seconds;
[0044] (e) Bond the treated PDMS to the glass slide and cure it at 65 °C for another 1 hour.
[0045] Specifically, it further includes the following steps:
[0046] (8) Inoculate cardiomyocytes in the microfluidic culture device, with a cell density of 1 - 5×105 cells / cm 2 ;
[0047] (9) Conduct electrophysiological property evaluation, including measuring the resting membrane potential, action potential amplitude, maximum depolarization rate, action potential duration, and beat frequency;
[0048] (10) Conduct optogenetic regulation experiments, including single - pulse stimulation, continuous light illumination, and high - frequency pulse stimulation.
[0049] Specifically, it further includes the following steps:
[0050] (11) Conduct drug response tests, using the potassium channel blocker E - 4031, the sodium channel blocker Tetrodotoxin, and the calcium channel blocker Nifedipine;
[0051] (12) Use paired t - tests or Wilcoxon signed - rank tests to compare the differences before and after treatment, and use one - way ANOVA to evaluate the differences in the effects of different light stimulation patterns;
[0052] (13) Evaluate the performance of the machine learning model, calculate the root - mean - square error, mean absolute error, and R 2 coefficient, and conduct K - fold cross - validation.
[0053] The beneficial effects of the present invention are mainly reflected in the following aspects:
[0054] The method of the present invention exhibits remarkable technical effects and advantages in multiple aspects. First, by simultaneously regulating the three main ion channels of sodium, potassium, and calcium, the electrophysiological properties of cardiomyocytes are comprehensively optimized, significantly improving the cell maturity and functional consistency. The specifically designed photosensitive ion channels not only improve the precision of light control but also maximize the retention of the inherent characteristics of the cells. This method of multi-channel cooperative regulation not only achieves the expected precise control but also unexpectedly demonstrates the ability to simulate complex pathological states, providing a leading platform for cardiac disease research.
[0055] Secondly, the three-dimensional microfluidic culture system developed in the present invention successfully simulates the in vivo microenvironment, significantly improving the cell morphology, arrangement, and functional connection. This not only enhances the physiological relevance of the cells but also unexpectedly discovers that it can simulate the extracellular matrix environment under different pathological states, providing a new tool for studying complex pathological processes such as myocardial fibrosis.
[0056] Furthermore, the introduction of a real-time feedback mechanism greatly improves the precision and flexibility of regulation. This can not only adjust parameters in a timely manner according to the dynamic changes of the cells but also demonstrates the ability to rapidly repair abnormal electrophysiological states, providing a powerful tool for studying dynamic pathological processes such as arrhythmia.
[0057] Finally, the integrated machine learning algorithm not only significantly improves the efficiency and precision of parameter optimization but also unexpectedly demonstrates the ability to predict the effects of new drugs on cardiomyocytes. This discovery provides a new way for rapid screening in drug development and is expected to greatly accelerate the research and development process of cardiovascular drugs.
[0058] It is worth noting that the method of the present invention also exhibits some unexpected technical effects. For example, long-term optogenetic regulation may affect the epigenetic modification status of certain ion channel genes, providing a new perspective for the regulation of cardiomyocyte function. In addition, cardiomyocytes cultured using this method show higher efficiency when reprogrammed into pluripotent stem cells, and this discovery may open up new directions for regenerative medicine research.
[0059] In summary, by innovatively integrating optogenetics, precise gene editing, advanced culture techniques, and artificial intelligence, the present invention not only successfully solves the technical problem of optimizing the electrophysiological properties of iPS-derived cardiomyocytes but also demonstrates broad application prospects in multiple aspects such as disease modeling, drug screening, and regenerative medicine. This interdisciplinary method represents the development trend of future precision medicine and personalized treatment and is expected to play an important role in the basic research and clinical application of cardiovascular diseases. Detailed implementation manners
[0060] To make the objectives, technical solutions, and advantages of the present invention clearer, the technical solutions of the present invention will be clearly and completely described below in conjunction with specific embodiments of the present invention. Obviously, the described embodiments are only a part of the embodiments of the present invention, rather than all of the embodiments. All other embodiments obtained by those of ordinary skill in the art based on the embodiments of the present invention without creative efforts fall within the scope of protection of the present invention.
[0061] Example 1
[0062] This example provides a method for optimizing the electrophysiological properties of iPS-derived cardiomyocytes based on optogenetic regulation. The method includes the following steps:
[0063] First, a specific light-sensitive ion channel gene is designed and constructed. In this example, a light-sensitive sodium channel gene OptoNav1.5 is designed, in which the transmembrane domains 4-7 (amino acid residues 784-971) of the light-sensitive protein ChR2 are inserted into the S3-S4 loop of Nav1.5. This design can achieve precise light control of the sodium ion channel, thereby regulating the depolarization process of cardiomyocytes.
[0064] Second, the specific light-sensitive ion channel gene is targeted and inserted into the iPS cell genome using the CRISPR / Cas9 system. The specific steps include: designing and synthesizing a specific gRNA (sequence: 5'-GCTAGCTAGCTAGCTAGCTA-3'), preparing a homologous recombination template containing the OptoNav1.5 gene and 1 kb homologous arms on both sides (total length approximately 8.7 kb). Then, 10 ng / μL of SpCas9 protein, gRNA, and the homologous recombination template are transfected into iPS cells using electroporation. The transfection parameters are set as voltage 1500 V, pulse width 10 ms, and number of pulses 1. Finally, resistance screening is performed using 0.5 μg / mL of puromycin for 48 hours.
[0065] Next, the iPS cells are induced to differentiate into cardiomyocytes. The small molecule induction method is adopted, and the specific steps are as follows: the cells are treated with 6 μM of CHIR99021 on days 0-1; the cells are cultured with the basal medium RPMI / B27 without insulin on days 2-3; the cells are treated with 5 μM of IWP-2 on days 3-5; and the cells are cultured with the RPMI / B27 medium containing insulin from day 5.
[0066] Then, the cardiomyocytes are subjected to light stimulation using a multi-wavelength LED array system. The LED array system used in this example includes: blue light LED (wavelength 470 nm, power density 10 mW / mm 2 ), yellow light LED (wavelength 590 nm, power density 5 mW / mm 2) and a green LED (wavelength 530 nm, power density 8 mW / mm 2 ).
[0067] Meanwhile, the electrophysiological properties of the cardiomyocytes are monitored in real time using a microelectrode array system. The microelectrode array system used includes 60 electrodes, with an electrode spacing of 200 μm, an electrode diameter of 30 μm, a sampling rate of 10 kHz, and a band-pass filter range of 0.1 Hz - 3 kHz.
[0068] Based on the monitoring results of the electrophysiological properties, the light stimulation parameters are optimized through a machine learning algorithm. In this embodiment, the random forest regression algorithm is adopted, with the number of trees being 100, the maximum depth being 5, and the minimum number of samples in a leaf node being 1.
[0069] Finally, the cardiomyocytes are cultured in a 3D-printed microfluidic culture device and optogenetic regulation is performed. The preparation method of the microfluidic culture device includes the following steps: preparing a microfluidic chip using PDMS, where the ratio of the PDMS matrix to the curing agent is 10:1 (w / w); making a mold using 3D printing technology, with a printing resolution of 25 μm and a printing speed of 1 cm / h; pouring the PDMS prepolymer into the mold and curing it at 65°C for 4 hours; treating the surfaces of the PDMS and the glass slide with plasma, with a power of 50 W and a time of 30 seconds; fitting the treated PDMS to the glass slide and curing it at 65°C for another 1 hour.
[0070] Preferably, in the embodiment of the present invention, the following steps are further included: inoculating cardiomyocytes in the microfluidic culture device, with a cell density of 1×10 5 cells / cm 2 ; performing electrophysiological property evaluation, including measuring the resting membrane potential, action potential amplitude, maximum depolarization rate, action potential duration, and beat frequency; performing optogenetic regulation experiments, including single-pulse stimulation (duration 1 ms), continuous light illumination (duration 1 s), and high-frequency pulse stimulation (frequency 10 Hz).
[0071] Example 2
[0072] This embodiment provides another method for optimizing the electrophysiological properties of iPS-derived cardiomyocytes based on optogenetic regulation, and this method includes the following steps:
[0073] First, a specific photosensitive ion channel gene is designed and constructed. In this embodiment, a photosensitive potassium channel gene OptoKv11.1 is designed, where the transmembrane domains 3 - 6 (amino acid residues 150 - 300) of the photosensitive protein Arch are inserted into the S5-P loop of Kv11.1. This design can achieve precise light control of the potassium ion channel, thereby regulating the repolarization process of cardiomyocytes.
[0074] Secondly, the specific photosensitive ion channel gene is targeted and inserted into the iPS cell genome using the CRISPR / Cas9 system. The specific steps include: designing and synthesizing a specific gRNA (sequence: 5'-ATCGATCGATCGATCGATCG-3'), preparing a homologous recombination template containing the OptoKv11.1 gene and 1 kb homologous arms on both sides (total length approximately 5.9 kb). Then, 30 ng / μL of SpCas9 protein, gRNA, and the homologous recombination template are transfected into iPS cells using electroporation. The transfection parameters are set as voltage 1600 V, pulse width 20 ms, and number of pulses 2. Finally, resistance screening is performed using 1 μg / mL of puromycin for 60 hours.
[0075] Next, the iPS cells are induced to differentiate into cardiomyocytes. The small molecule induction method is adopted, and the specific steps are as follows: The cells are treated with 9 μM of CHIR99021 on days 0-1; the cells are cultured with the basal medium RPMI / B27 without insulin on days 2-3; the cells are treated with 7.5 μM of IWP-2 on days 3-5; and the cells are cultured with the RPMI / B27 medium containing insulin starting from day 5.
[0076] Then, the cardiomyocytes are subjected to light stimulation using a multi-wavelength LED array system. The LED array system used in this example includes: blue light LED (wavelength 470 nm, power density 25 mW / mm 2 ), yellow light LED (wavelength 590 nm, power density 15 mW / mm 2 ), and green light LED (wavelength 530 nm, power density 20 mW / mm 2 ).
[0077] Meanwhile, the electrophysiological properties of the cardiomyocytes are monitored in real time using a microelectrode array system. The microelectrode array system used includes 60 electrodes, the electrode spacing is 200 μm, the electrode diameter is 30 μm, the sampling rate is 30 kHz, and the bandpass filter range is 0.1 Hz - 3 kHz.
[0078] Based on the monitoring results of the electrophysiological properties, the light stimulation parameters are optimized through a machine learning algorithm. In this example, the support vector machine regression algorithm is adopted, using the radial basis function kernel, with the C parameter being 10 and the gamma parameter being 0.01.
[0079] Finally, culture the cardiomyocytes in the 3D printed microfluidic culture device and perform optogenetic regulation. The preparation method of the microfluidic culture device includes the following steps: prepare a microfluidic chip using PDMS, where the ratio of the PDMS matrix to the curing agent is 10:1 (w / w); use 3D printing technology to make a mold with a printing resolution of 60 μm and a printing speed of 3 cm / h; pour the PDMS prepolymer into the mold and cure it at 65 °C for 5 hours; treat the surfaces of the PDMS and the glass slide with plasma at a power of 75 W for 45 seconds; bond the treated PDMS to the glass slide and cure it at 65 °C for another 1 hour.
[0080] Preferably, in the embodiments of the present invention, the following steps are further included: inoculate cardiomyocytes in the microfluidic culture device at a cell density of 3×10 5 cells / cm 2 ; perform electrophysiological property evaluation, including measuring the resting membrane potential, action potential amplitude, maximum depolarization rate, action potential duration, and beat frequency; perform optogenetic regulation experiments, including single-pulse stimulation (duration 5 ms), continuous light illumination (duration 30 s), and high-frequency pulse stimulation (frequency 50 Hz).
[0081] Example 3
[0082] This example provides another method for optimizing the electrophysiological properties of iPS-derived cardiomyocytes based on optogenetic regulation. The method includes the following steps:
[0083] First, design and construct a specific photosensitive ion channel gene. In this example, a photosensitive calcium channel gene OptoCav1.2 was designed, in which the transmembrane domains 2-5 (amino acid residues 88-260) of the photosensitive protein VChR1 were inserted into the III-IV loop of Cav1.2. This design can achieve precise optical control of the calcium ion channel, thereby regulating the contractility and automatic rhythm of cardiomyocytes.
[0084] Second, use the CRISPR / Cas9 system to targetedly insert the specific photosensitive ion channel gene into the iPS cell genome. The specific steps include: design and synthesize a specific gRNA (sequence: 5'-CGTAGCTAGCTAGCTAGCTA-3'), prepare a homologous recombination template containing the OptoCav1.2 gene and 1 kb homologous arms on both sides (total length about 9.2 kb). Then, use electroporation to transfect 50 ng / μL of SpCas9 protein, gRNA, and the homologous recombination template into iPS cells. The transfection parameters are set as voltage 1700 V, pulse width 30 ms, and pulse number 3 times. Finally, perform resistance screening with 2 μg / mL of puromycin for 72 hours.
[0085] Next, induce the differentiation of the iPS cells into cardiomyocytes. The small molecule induction method is used, and the specific steps are as follows: Treat the cells with 12 μM of CHIR99021 on days 0-1; culture the cells with the basal medium RPMI / B27 without insulin on days 2-3; treat the cells with 10 μM of IWP-2 on days 3-5; start culturing the cells with the RPMI / B27 medium containing insulin from day 5.
[0086] Then, use a multi-wavelength LED array system to perform light stimulation on the cardiomyocytes. The LED array system used in this embodiment includes: blue LEDs (wavelength 470 nm, power density 50 mW / mm 2 ), yellow LEDs (wavelength 590 nm, power density 30 mW / mm 2 ), and green LEDs (wavelength 530 nm, power density 40 mW / mm 2 ).
[0087] Meanwhile, use a microelectrode array system to monitor the electrophysiological properties of the cardiomyocytes in real time. The microelectrode array system used includes 60 electrodes, the electrode spacing is 200 μm, the electrode diameter is 30 μm, the sampling rate is 50 kHz, and the bandpass filter range is 0.1 Hz - 3 kHz.
[0088] Based on the monitoring results of the electrophysiological properties, optimize the light stimulation parameters through a machine learning algorithm. In this embodiment, a deep neural network algorithm is used, with 10 layers, 512 neurons in each layer, the activation function is ReLU, the optimizer is Adam, and the learning rate is 0.0001.
[0089] Finally, culture the cardiomyocytes in a 3D printed microfluidic culture device and perform optogenetic regulation. The preparation method of the microfluidic culture device includes the following steps: Prepare a microfluidic chip using PDMS, where the ratio of the PDMS matrix to the curing agent is 10:1 (w / w); Use 3D printing technology to make a mold, with a printing resolution of 100 μm and a printing speed of 5 cm / h; Pour the PDMS prepolymer into the mold and cure it at 65°C for 6 hours; Treat the surfaces of the PDMS and the glass slide with plasma, with a power of 100 W and a time of 60 seconds; Fit the treated PDMS to the glass slide and cure it at 65°C for another 1 hour.
[0090] Preferably, in the embodiments of the present invention, the following steps are further included: Inoculate cardiomyocytes in the microfluidic culture device, and the cell density is 5×10 5 cells / cm 2; perform electrophysiological property evaluations, including measuring the resting membrane potential, action potential amplitude, maximum depolarization rate, action potential duration, and beating frequency; conduct optogenetic regulation experiments, including single-pulse stimulation (duration 10 ms), continuous light illumination (duration 60 s), and high-frequency pulse stimulation (frequency 100 Hz).
[0091] Example 4
[0092] This example provides an optogenetic-regulation-based method for optimizing the electrophysiological properties of iPS-derived cardiomyocytes that combines the advantages of the first three examples. The method includes the following steps:
[0093] First, simultaneously design and construct three specific photosensitive ion channel genes: OptoNav1.5, OptoKv11.1, and OptoCav1.2. This combination enables simultaneous precise optical control of sodium, potassium, and calcium ion channels, thereby comprehensively regulating the electrophysiological properties of cardiomyocytes.
[0094] Second, use the CRISPR / Cas9 system to simultaneously target and insert the three specific photosensitive ion channel genes into the iPS cell genome. The specific steps include: designing and synthesizing three specific gRNAs, preparing a homologous recombination template containing the three photosensitive ion channel genes and corresponding homologous arms. Then, use electroporation to transfect a mixture of 30 ng / μL of SpCas9 protein, the three gRNAs, and the homologous recombination template into iPS cells. The transfection parameters are set to a voltage of 1600 V, a pulse width of 20 ms, and the number of pulses is 2 times. Finally, perform 60-hour resistance screening using 1.5 μg / mL of puromycin.
[0095] Next, induce the iPS cells to differentiate into cardiomyocytes. Adopt the small molecule induction method, and the specific steps are as follows: treat the cells with 9 μM of CHIR99021 on days 0-1; culture the cells with the basal medium RPMI / B27 without insulin on days 2-3; treat the cells with 7.5 μM of IWP-2 on days 3-5; start culturing the cells with the RPMI / B27 medium containing insulin from day 5.
[0096] Then, use a multi-wavelength LED array system to perform light stimulation on the cardiomyocytes. The LED array system used in this example includes: blue light LED (wavelength 470 nm, power density 25 mW / mm 2 ), yellow light LED (wavelength 590 nm, power density 15 mW / mm 2 ), and green light LED (wavelength 530 nm, power density 20 mW / mm 2 ). This combination can simultaneously activate the three photosensitive ion channels and achieve comprehensive regulation of the electrophysiological properties of cardiomyocytes.
[0097] Meanwhile, a microelectrode array system is used to monitor the electrophysiological properties of the cardiomyocytes in real time. The microelectrode array system used includes 60 electrodes with an electrode spacing of 200 μm, an electrode diameter of 30 μm, a sampling rate of 30 kHz, and a band-pass filter range of 0.1 Hz - 3 kHz.
[0098] Based on the monitoring results of the electrophysiological properties, the optogenetic stimulation parameters are optimized through a machine learning algorithm. In this embodiment, an ensemble learning method is adopted, combining the advantages of random forest, support vector machine, and deep neural network. The specific parameters are as follows: random forest (the number of trees is 500, the maximum depth is 25); support vector machine (C parameter is 1, gamma parameter is 0.1); deep neural network (the number of layers is 5, the number of neurons in each layer is 256, the activation function is ReLU, the optimizer is Adam, and the learning rate is 0.0005).
[0099] Finally, the cardiomyocytes are cultured in a 3D printed microfluidic culture device and optogenetic regulation is carried out. The preparation method of the microfluidic culture device includes the following steps: using PDMS to prepare a microfluidic chip, where the ratio of PDMS matrix to curing agent is 10:1 (w / w); using 3D printing technology to make a mold with a printing resolution of 50 μm and a printing speed of 3 cm / h; pouring the PDMS prepolymer into the mold and curing it at 65°C for 5 hours; treating the surfaces of PDMS and glass slides with plasma at a power of 75 W for 45 seconds; fitting the treated PDMS with the glass slide and curing it at 65°C for another 1 hour.
[0100] Preferably, in the embodiment of the present invention, the following steps are further included: inoculating cardiomyocytes in the microfluidic culture device with a cell density of 3×10 5 cells / cm 2 ; performing electrophysiological property evaluation, including measuring the resting membrane potential, action potential amplitude, maximum depolarization rate, action potential duration, and beat frequency; performing optogenetic regulation experiments, including single-pulse stimulation (duration 5 ms), continuous light illumination (duration 30 s), and high-frequency pulse stimulation (frequency 50 Hz).
[0101] In addition, drug response tests are also carried out in this embodiment, using the potassium channel blocker E-4031 (concentration range 0.1 - 100 nM), the sodium channel blocker Tetrodotoxin (concentration range 0.1 - 100 μM), and the calcium channel blocker Nifedipine (concentration range 0.1 - 100 μM). By comparing the drug response differences before and after optogenetic regulation, the influence mechanism of optogenetic regulation on the electrophysiological properties of cardiomyocytes can be deeply understood.
[0102] Finally, a paired t-test was used to compare the differences before and after treatment, and one-way ANOVA was used to evaluate the differences in the effects of different light stimulation patterns. Meanwhile, the performance of the machine learning model was evaluated, the root mean square error, mean absolute error, and R 2 -coefficient were calculated, and 10-fold cross-validation was performed to ensure the stability and generalization ability of the model.
[0103] Through this comprehensive method, this embodiment achieved the comprehensive optimization and precise regulation of the electrophysiological properties of iPS-derived cardiomyocytes, providing a highly reliable and flexible cell platform for heart disease modeling and drug screening. Optimization method for electrophysiological properties of iPS-derived cardiomyocytes based on optogenetic regulation
[0104] Comparative Example 1: Single photosensitive ion channel gene
[0105] This comparative example aims to verify the superiority of simultaneously introducing multiple photosensitive ion channel genes and is compared with Example 4. This method includes the following steps:
[0106] First, only the photosensitive sodium channel gene OptoNav1.5 was designed and constructed. Second, the OptoNav1.5 gene was targeted and inserted into the iPS cell genome using the CRISPR / Cas9 system, and the specific steps were the same as those in Example 1. Then, the iPS cells were induced to differentiate into cardiomyocytes according to the method of Example 4.
[0107] Next, a single-wavelength LED (blue light, wavelength 470 nm, power density 25 mW / mm 2 ) was used to perform light stimulation on the cardiomyocytes. Meanwhile, the same microelectrode array system as in Example 4 was used to monitor the electrophysiological properties of the cells. Based on the monitoring results, a single random forest algorithm (the number of trees was 500, and the maximum depth was 25) was used to optimize the light stimulation parameters.
[0108] Finally, the cardiomyocytes were cultured in the same three-dimensional printed microfluidic culture device as in Example 4 and subjected to optogenetic regulation. The methods for electrophysiological property evaluation and drug response testing were the same as those in Example 4.
[0109] The results showed that compared with Example 4, the cardiomyocytes in this comparative example showed obvious limitations in terms of action potential morphology, repolarization time, and drug sensitivity, confirming the importance of simultaneously regulating multiple ion channels.
[0110] Comparative Example 2: Nonspecific photosensitive protein
[0111] This comparative example aims to verify the necessity of designing specific photosensitive ion channel genes and is compared with Example 2. This method includes the following steps:
[0112] First, construct a gene expressing the non-specific photosensitive protein ChR2. Second, use a lentiviral vector to transduce the ChR2 gene into iPS cells with a virus titer of 1×10 8 TU / mL and an MOI of 10. Then, induce the differentiation of iPS cells into cardiomyocytes according to the method of Example 2.
[0113] Next, use the same multi-wavelength LED array system as in Example 2 to perform light stimulation on the cardiomyocytes. The electrophysiological monitoring and machine learning algorithm optimization steps are the same as those in Example 2.
[0114] Finally, culture the cardiomyocytes in the same microfluidic culture device as in Example 2 and perform optogenetic regulation. The methods for evaluating electrophysiological characteristics and drug response tests are the same as those in Example 2.
[0115] The results show that, compared with Example 2, the cardiomyocytes in this comparative example exhibited non-specific ion currents under light stimulation, resulting in a significant reduction in the regulation accuracy of electrophysiological characteristics, confirming the importance of designing specific photosensitive ion channel genes.
[0116] Comparative Example 3: Traditional culture method
[0117] This comparative example aims to verify the superiority of the three-dimensional printed microfluidic culture device by comparing it with Example 3. The method includes the following steps:
[0118] Design and construct the photosensitive calcium channel gene OptoCav1.2 according to the method of Example 3 and targetedly insert it into the iPS cell genome. Then, induce the differentiation of iPS cells into cardiomyocytes according to the method of Example 3.
[0119] Next, culture the cardiomyocytes in a traditional planar culture dish. Use the same LED array system as in Example 3 for light stimulation, but due to the limitation of planar culture, the light distribution is uneven. The electrophysiological monitoring and machine learning algorithm optimization steps are the same as those in Example 3.
[0120] Finally, the methods for evaluating electrophysiological characteristics and drug response tests are the same as those in Example 3.
[0121] The results show that, compared with Example 3, the cardiomyocytes in this comparative example performed poorly in terms of growth state, uniformity of electrophysiological characteristics, and response consistency to light stimulation, confirming the important role of the three-dimensional printed microfluidic culture device in providing a uniform growth environment and light conditions.
[0122] Comparative Example 4: No real-time feedback mechanism
[0123] This comparative example aims to verify the importance of the real-time feedback mechanism by comparing it with Example 1. The method includes the following steps:
[0124] Design and construct the photosensitive sodium channel gene OptoNav1.5 according to the method of Example 1, and targetedly insert it into the iPS cell genome. Then, induce the differentiation of iPS cells into cardiomyocytes according to the method of Example 1.
[0125] Next, use the same LED array system as in Example 1 to perform light stimulation on the cardiomyocytes, but without real-time electrophysiological monitoring and parameter optimization. Instead, use a preset fixed light stimulation pattern (such as a single-pulse stimulation of 10 ms, repeated 60 times per minute).
[0126] Finally, culture the cardiomyocytes in the same microfluidic culture device as in Example 1 and perform optogenetic regulation. The methods for evaluating electrophysiological properties and drug response testing are the same as those in Example 1.
[0127] The results show that, compared with Example 1, the regulation effect of the electrophysiological properties of the cardiomyocytes in this comparative example is poor, and it is difficult to adapt to the dynamic changes of the cell state, which confirms the key role of the real-time feedback mechanism in precisely regulating the electrophysiological properties of cardiomyocytes.
[0128] Comparative Example 5: Simple machine learning algorithm
[0129] This comparative example aims to verify the necessity of complex machine learning algorithms by comparing with Example 4. The method includes the following steps:
[0130] Design and construct three photosensitive ion channel genes according to the method of Example 4, and targetedly insert them into the iPS cell genome. Then, induce the differentiation of iPS cells into cardiomyocytes according to the method of Example 4.
[0131] Next, use the same LED array system and microelectrode array system as in Example 4 for light stimulation and electrophysiological monitoring. However, when optimizing the light stimulation parameters, only use a simple linear regression algorithm instead of an ensemble learning method.
[0132] Finally, culture the cardiomyocytes in the same microfluidic culture device as in Example 4 and perform optogenetic regulation. The methods for evaluating electrophysiological properties and drug response testing are the same as those in Example 4.
[0133] The results show that, compared with Example 4, the optimization effect of the light stimulation parameters in this comparative example is poor, and it is difficult to capture complex non-linear relationships, resulting in a significant reduction in the accuracy and efficiency of regulating the electrophysiological properties of cardiomyocytes, which confirms the importance of complex machine learning algorithms in dealing with multi-variable, non-linear systems.
[0134] Comparative Example 6: Traditional drug regulation method
[0135] This comparative example aims to verify the superiority of optogenetic regulation methods over traditional drug regulation methods and is compared with Example 2. This method includes the following steps:
[0136] Induce the differentiation of iPS cells into cardiomyocytes according to the method of Example 2, but do not transfect the photosensitive ion channel gene. Then, culture the cardiomyocytes in the same microfluidic culture device as in Example 2.
[0137] Next, use a drug cocktail to regulate the electrophysiological properties of cardiomyocytes, including the sodium channel agonist veratridine (0.1 - 10 μM), the potassium channel blocker E-4031 (1 - 100 nM), and the calcium channel modulator Bay K 8644 (0.1 - 10 μM). Use the same microelectrode array system as in Example 2 to monitor the electrophysiological properties of the cells.
[0138] Finally, the methods for electrophysiological property evaluation and drug response testing are the same as in Example 2.
[0139] The results show that compared with Example 2, the time resolution of electrophysiological property regulation of cardiomyocytes in this comparative example is lower, it is difficult to achieve rapid and reversible regulation, and the non-specific effects of drugs may introduce additional variables. This confirms the significant advantages of optogenetic-based regulation methods in terms of precision, time resolution, and reversibility.
[0140] Through the above six comparative examples, the innovation and superiority of the present invention in multiple key aspects have been comprehensively verified, including multi-channel collaborative regulation, specific design, advanced culture technology, real-time feedback mechanism, complex algorithm optimization, and advantages over traditional methods. These results fully demonstrate the important contribution and potential application value of the present invention in optimizing the electrophysiological properties of iPS-derived cardiomyocytes. Evaluation of the effectiveness of the method for optimizing the electrophysiological properties of iPS-derived cardiomyocytes based on optogenetic regulation
[0141] To comprehensively evaluate the effectiveness of the method of the present invention, a series of test experiments were designed. These experiments aim to verify the core innovations of the present invention, including the superiority in aspects such as multi-channel collaborative regulation, specific photosensitive ion channel design, three-dimensional microfluidic culture technology, real-time feedback mechanism, and machine learning algorithm optimization.
[0142] Experiment 1: Evaluation of the effect of multi-channel collaborative regulation
[0143] Experimental conditions: Use the cardiomyocyte samples of Example 4 and Comparative Examples 1 - 3.
[0144] Experimental method:
[0145] 1. Place the cardiomyocytes on a multi-electrode array (MEA) plate.
[0146] 2. Perform single-channel (sodium, potassium, or calcium) and multi-channel simultaneous optical stimulations separately.
[0147] 3. Record the action potential waveform, duration (APD), and maximum rate of depolarization (dV / dt max).
[0148] 4. Measure the change in intracellular calcium ion concentration using the calcium indicator Fluo-4AM.
[0149] Results:
[0150] Table 1. Comparison of electrophysiological parameters of cardiomyocytes under different optical stimulation conditions
[0151] Sample APD90 (ms) dV / dtmax (V / s) <![CDATA[Ca 2 + Transient amplitude (F / F0)]]> Example 4 285±15 220±12 3.8±0.2 Comparative Example 1 320±18 180±10 2.5±0.3 Comparative Example 2 305±20 195±15 3.0±0.3 Comparative Example 3 310±22 190±14 2.8±0.4
[0152] Results analysis: Example 4 exhibits electrophysiological parameters and calcium ion kinetics closest to the physiological state, demonstrating the superiority of multi-channel cooperative regulation.
[0153] Experiment 2: Specificity evaluation of photosensitive ion channels
[0154] Experimental conditions: Use the cardiomyocyte samples of Example 2 and Comparative Example 2.
[0155] Experimental methods:
[0156] 1. Record the single ion channel current using the patch clamp technique.
[0157] 2. Measure the channel currents of various ions (Na + , K + , Ca 2+ ) under light stimulations of different wavelengths (470 nm, 530 nm, 590 nm).
[0158] 3. Calculate the light sensitivity and selectivity of each channel.
[0159] Results:
[0160] Table 2. Specificity comparison of photosensitive ion channels
[0161]
[0162] Results analysis: The specific design in Example 2 significantly improves the light sensitivity and selectivity, laying a foundation for precise regulation.
[0163] Experiment 3: Evaluation of three-dimensional microfluidic culture technology
[0164] Experimental conditions: Use the cardiomyocyte samples of Example 3 and Comparative Example 3.
[0165] Experimental methods:
[0166] 1. Observe cell morphology and arrangement using a confocal microscope.
[0167] 2. Measure cell metabolic activity (MTT assay) and viability (Live / Dead staining).
[0168] 3. Evaluate the expression level of the intercellular junction protein (Connexin43).
[0169] Results:
[0170] Table 3. Comparison of cardiomyocyte characteristics under different culture conditions
[0171]
[0172] Results analysis: The three-dimensional microfluidic culture technology significantly improved the cell growth environment and enhanced cell activity and functional connectivity.
[0173] Experiment 4: Evaluation of the effect of the real-time feedback mechanism
[0174] Experimental conditions: Use the cardiomyocyte samples of Example 1 and Comparative Example 4.
[0175] Experimental methods:
[0176] 1. Record the stability of action potentials under electrical stimulation at different frequencies (1 - 5 Hz).
[0177] 2. Measure the coefficient of variation of APD90 after 100 consecutive light stimulations.
[0178] 3. Evaluate the regulatory effect in a sudden arrhythmia model (induced by brief high potassium treatment).
[0179] Results:
[0180] Table 4. Effect of the real-time feedback mechanism on the electrophysiological stability of cardiomyocytes
[0181]
[0182] Results analysis: The real-time feedback mechanism significantly improved the stability of electrophysiological characteristics and the ability to repair abnormal states.
[0183] Experiment 5: Evaluation of the optimization effect of machine learning algorithms
[0184] Experimental conditions: Use the cardiomyocyte samples of Example 4 and Comparative Example 5.
[0185] Experimental methods:
[0186] 1. Set complex light stimulation sequences (including combinations of different intensities, durations, and patterns).
[0187] 2. Record the deviation between the optimal parameters predicted by the algorithm and the actual optimal parameters.
[0188] 3. Evaluate the generalization ability of the algorithm on new samples.
[0189] 4. Measure the computational time required for parameter optimization.
[0190] Results:
[0191] Table 5. Performance of different machine learning methods in optimizing optogenetic parameters
[0192] Sample Parameter prediction accuracy (%) Generalization error (RMSE) Optimization time (s) Example 4 92±3 0.15±0.02 5±1 Comparative Example 5 78±5 0.35±0.05 15±3
[0193] Result analysis: Complex machine learning algorithms have significantly improved the accuracy and efficiency of parameter optimization, especially in dealing with complex, non-linear relationships.
[0194] Comprehensive analysis and unexpected technical effects:
[0195] Through the above series of experiments, not only the core innovation points of the present invention have been verified, but also some unexpected technical effects have been discovered:
[0196] 1. Synergistic effect: Multichannel simultaneous regulation not only achieves the expected precise control, but also unexpectedly discovers that it can simulate complex pathological states, such as long QT syndrome or atrial fibrillation. This provides a leading platform for disease modeling and drug screening.
[0197] 2. Epigenetic regulation: It is unexpectedly found that long-term optogenetic regulation can affect the epigenetic modification status of certain ion channel genes, such as changes in DNA methylation levels. This discovery provides a new perspective for the functional regulation of cardiomyocytes.
[0198] 3. Enhanced cell reprogramming: During the experiment, it was observed that when cardiomyocytes cultured using this method were reprogrammed into pluripotent stem cells, the efficiency was about 30% higher than that of traditional methods. This may be related to the effect of optogenetic regulation on cell metabolism and epigenetic status.
[0199] 4. Drug response prediction: Machine learning algorithms not only optimize optogenetic parameters, but also unexpectedly show the ability to predict the effects of new drugs on cardiomyocytes. This provides a rapid screening tool for drug development.
[0200] 5. Microenvironment adaptability: The three-dimensional microfluidic culture system shows unexpected adaptability and can simulate the extracellular matrix environment under different pathological states, providing a new tool for studying pathological processes such as myocardial fibrosis.
[0201] These unexpected technical effects further highlight the innovation and potential application value of the present invention. By integrating optogenetics, precise gene editing, advanced culture techniques, and artificial intelligence, this method not only optimizes the electrophysiological properties of iPS-derived cardiomyocytes but also opens up new research directions for cardiac pathology research, drug development, and regenerative medicine. This interdisciplinary approach represents the future development trend of precision medicine and personalized treatment and is expected to play an important role in the basic research and clinical applications of cardiovascular diseases.
[0202] The above are only embodiments of the present invention and are not intended to limit the present invention. For those skilled in the art, various modifications and changes can be made to the present invention. Any modifications, equivalent replacements, improvements, etc. made within the spirit and principle of the present invention shall be included within the scope of the claims of the present invention.
Claims
1. A method for optimizing the electrophysiological properties of iPS-derived cardiomyocytes based on optogenetic regulation, characterized in that: The following steps are involved: (1) Design and construct specific light-sensitive ion channel genes; (2) inserting the specific light-sensitive ion channel gene into the iPS cell genome; (3) inducing the iPS cells to differentiate into cardiomyocytes; (4) using a multi-wavelength LED array system to light stimulate the cardiomyocytes; (5) using a microelectrode array system to monitor the electrophysiological characteristics of the cardiomyocytes in real time; (6) optimizing light stimulation parameters through a machine learning algorithm based on the monitoring results of the electrophysiological characteristics; (7) Cultivating the cardiomyocytes in a three-dimensional printed microfluidic culture device and performing optogenetic regulation.
2. The method according to claim 1, characterized in that The specific photosensitive ion channel gene in step (1) comprises: The photosensitive sodium channel gene OptoNav1.5, in which the transmembrane domains 4-7 of the photosensitive protein ChR2 are inserted into the S3-S4 loop of Nav1.5; The light-sensitive potassium channel gene OptoKv11.1, in which the transmembrane domains 3-6 of the light-sensitive protein Arch are inserted into the S5-P loop of Kv11.1; The photosensitive calcium channel gene OptoCav1.2, in which the transmembrane domains 2-5 of the photosensitive protein VChR1 are inserted into the III-IV ring of Cav1.
2.
3. The method according to claim 1, characterized in that The step (2) uses the CRISPR / Cas9 system to perform genome targeted insertion, which specifically includes the following steps: (a) Design and synthesize specific gRNA; (b) preparing a homologous recombination template comprising a photosensitive ion channel gene and 1 kb homology arms on both sides; (c) Using electroporation, Cas9 protein, gRNA and homologous recombination template are transfected into iPS cells; (d) Resistance screening using puromycin.
4. The method according to claim 1, characterized in that The myocardial differentiation method in step (3) is a small molecule induction method, comprising the following steps: (a) Cells were treated with CHIR99021 at concentrations of 6–12 μM on day 0–1; (b) Cells were cultured using basal medium RPMI / B27 without insulin on days 2-3; (c) cells were treated with IWP-2 at a concentration of 5–10 μM on days 3–5; (d) Cells were cultured using RPMI / B27 medium containing insulin starting from day 5.
5. The method according to claim 1, characterized in that: The multi-wavelength LED array system in step (4) comprises: Blue LED, wavelength 470±5nm, power density 0-50mW / mm 2 ; Yellow LED, wavelength 590±5nm, power density 0-30mW / mm 2 ; Green LED, wavelength 530±5nm, power density 0-40mW / mm 2 .
6. The method according to claim 1, characterized in that The microelectrode array system used in step (5) includes 60 electrodes, with an electrode spacing of 200 μm, an electrode diameter of 30 μm, a sampling rate of 10-50 kHz, and a bandpass filter range of 0.1 Hz-3 kHz.
7. The method according to claim 1, characterized in that The machine learning algorithm in step (6) includes random forest regression, support vector machine regression and deep neural network, wherein: The number of trees for random forest regression is 100-1000, the maximum depth is 5-50, and the minimum number of leaf node samples is 1-10; Support vector machine regression uses a radial basis function kernel with a C parameter range of 0.1-100 and a gamma parameter range of 0.001-1; The number of layers of the deep neural network is 3-10, the number of neurons in each layer is 32-512, the activation function is ReLU, the optimizer is Adam, and the learning rate is 0.0001-0.
01.
8. The method according to claim 1, characterized in that The method for preparing the three-dimensional printed microfluidic culture device in step (7) comprises the following steps: (a) A microfluidic chip was prepared using PDMS, wherein the ratio of PDMS matrix to curing agent was 10:1 (w / w); (b) The mold was made using 3D printing technology with a printing resolution of 25-100 μm and a printing speed of 1-5 cm / h; (c) pouring the PDMS prepolymer into the mold and curing it at 65 °C for 4-6 hours; (d) treating the PDMS and glass slide surfaces with plasma at a power of 50–100 W for 30–60 s; (e) The treated PDMS was bonded to a glass sheet and cured at 65 °C for another hour.
9. The method according to claim 1, characterized in that: The following steps are also included: (8) Inoculating cardiomyocytes in the microfluidic culture device at a cell density of 1-5×105 cells / cm 2 ; (9) Conduct electrophysiological property assessment, including measurement of resting membrane potential, action potential amplitude, maximum depolarization rate, action potential duration, and beat frequency; (10) Conduct optogenetic regulation experiments, including single pulse stimulation, continuous illumination, and high-frequency pulse stimulation.
10. The method according to claim 1, characterized in that The following steps are also included: (11) Conduct drug response tests using potassium channel blocker E-4031, sodium channel blocker Tetrodotoxin, and calcium channel blocker Nifedipine; (12) Paired t-test or Wilcoxon signed-rank test were used to compare the differences before and after treatment, and one-way analysis of variance was used to evaluate the differences in the effects of different light stimulation modes; (13) Evaluate the performance of the machine learning model and calculate the root mean square error, mean absolute error, and R 2 Coefficients, perform K-fold cross validation.